Notch signaling induces cytoplasmic CD3ε expression in human differentiating NK cells

Blood

Volumn 110, Issue 7, 2007, Pages 2696-2703

  De Smedt, Magda ^a   Taghon, Tom ^a   Van De Walle, Inge ^a   De Smet, Greet ^a   Leclercq, Georges ^a   Plum, Jean ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; NOTCH RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; CELL SPECIFICITY; COCULTURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD56; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOPLASM; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; PHENOTYPE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; THYMUS GLAND; TIME FACTORS;

EID: 34948883510     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-03-082206     Document Type: Article

References (38)

1. Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol. 2006;7:1217-1224.
2. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med. 1992;175:1055-1066.
3. Biassoni R, Ferrini S, Prigione I, Moretta A, Long EO. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. J Immunol. 1988;140:1685-1689.
4. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells: implications for the relationship of NK and T lymphocytes. J Immunol. 1992;149:1876-1880.
5. Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965-973.
6. Ehebauer M, Hayward P, Arias AM. Notch, a universal arbiter of cell fate decisions. Science. 2006;314:1414-1415.
7. Rothenberg EV, Yui MA, Telfer JC. T-cell developmental biology. In: Paul WE, ed. Fundamental Immunology. 5th ed. Philadelphia (PA): Lippincott Williams & Wilkins. 2003;259-319.
8. Maillard I, Adler SH, Pear WS. Notch and the immune system. Immunity. 2003;19:781-791.
9. Maillard I, Weng AP, Carpenter AC, et al. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 2004;104:1696-1702.
10. De Smedt M, Reynvoet K, Kerre T, et al. Active form of Notch imposes T cell fate in human progenitor cells. J Immunol. 2002;169:3021-3029.
11. De Smedt M, Hoebeke I, Plum J. Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment. Blood Cells Mol Dis. 2004;33:227-232.
12. De Smedt M, Hoebeke I, Reynvoet K, Leclercq G, Plum J. Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood. 2005;106:3498-3506.
13. + fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood. 1994;84:1587-1593.
14. La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC. Induction of T cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood. 2005;105:1431-1439.
15. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580-596.
16. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65-78.
17. Radtke F, Wilson A, Stark G, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 1999;10:547-558.
18. Mingari MC, Poggi A, Biassoni R, et al. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. J Exp Med. 1991;174:21-26.
19. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006;203:1033-1043.
20. Chiba S. Notch signaling in stem cell systems. Stem Cells. 2006;24:2437-2447.
21. Yan XQ, Sarmiento U, Sun Y, et al. A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood. 2001;98:3793-3799.
22. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol. 2004;173:6547-6563.
23. Taghon TN, David ES, Zuniga-Pflucker JC, Rothenberg EV. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 2005;19:965-978.
24. Jaleco AC, Neves H, Hooijberg E, et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med. 2001;194:991-1002.
25. Lehar SM, Dooley J, Farr AG, Bevan MJ. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood. 2005;105:1440-1447.
26. Garcia-Peydro M, de Yebenes VG, Toribio ML. Sustained Notch1 signaling instructs the earliest human intrathymic precursors to adopt a gammadelta T-cell fate in fetal thymus organ culture. Blood. 2003;102:2444-2451.
27. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995;85:2654-2670.
28. Carotta S, Brady J, Wu L, Nutt SL. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells. Eur J Immunol. 2006;36:3294-3304.
29. Rolink AG, Balciunaite G, Demoliere C, Ceredig R. The potential involvement of Notch signaling in NK cell development. Immunol Lett. 2006;107:50-57.
30. Karanu FN, Murdoch B, Miyabayashi T, et al. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood. 2001;97:1960-1967.
31. Renard V, Ardouin L, Malissen M, et al. Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice. Proc Natl Acad Sci U S A. 1995;92:7545-7549.
32. Wang B, Biron C, She J, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A. 1994;91:9402-9406.
33. Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in TgE26 mice. Biol Reprod. 1997;56:169-179.
34. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2006;20:123-137.
35. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004;172:1455-1462.
36. dim cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179:89-94.
37. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19:2186-2194.
38. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269-271.